Victory Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5K Buy
+10,275
New +$44.5K ﹤0.01% 2351
2025
Q1
Sell
-10,156
Closed -$109K 2478
2024
Q4
$109K Sell
10,156
-269
-3% -$2.07K ﹤0.01% 2330
2024
Q3
$59.2K Sell
10,425
-172
-2% -$992 ﹤0.01% 2377
2024
Q2
$44.7K Buy
10,597
+127
+1% +$514 ﹤0.01% 2381
2024
Q1
$53.3K Sell
10,470
-247
-2% -$1.39K ﹤0.01% 2371
2023
Q4
$99.8K Buy
+10,717
New +$73.8K ﹤0.01% 2344
2022
Q3
Sell
-17,097
Closed -$171K 2707
2022
Q2
$171K Sell
17,097
-10,900
-39% -$103K ﹤0.01% 2382
2022
Q1
$240K Buy
27,997
+5,404
+24% +$66.5K ﹤0.01% 2366
2021
Q4
$392K Buy
22,593
+10,783
+91% +$205K ﹤0.01% 2289
2021
Q3
$212K Buy
+11,810
New +$235K ﹤0.01% 2505

Other funds holding AVXL